No, Multiple Myeloma Does Not Cause Polycythemia
Multiple myeloma characteristically causes anemia, not polycythemia. Anemia is present in approximately 75% of patients at diagnosis and occurs in almost all patients with uncontrolled disease 1. The anemia is typically normochromic and normocytic.
Why Multiple Myeloma Causes Anemia
The pathophysiology of anemia in multiple myeloma involves several mechanisms 1:
- Bone marrow infiltration by myeloma cells leads to reduced numbers of erythroid precursors
- Myeloma cells induce apoptosis of erythroblasts (this is the major cause)
- Erythropoietin deficiency in patients with renal impairment
- Decreased responsiveness of pro-erythroblasts and CFU-E cells to erythropoietin
- Impaired iron utilization due to increased hepcidin production from chronic inflammation
- Paraprotein-induced increase in plasma volume (dilutional effect)
- Anti-myeloma therapy and radiotherapy can worsen pre-existing anemia
The Rare Exception: Concurrent Polycythemia
While polycythemia with multiple myeloma is extremely rare, a handful of case reports document this unusual combination 2, 3, 4, 5, 6:
- These represent concurrent but separate disease processes, not a causal relationship
- Most documented cases involve polycythemia vera (a separate myeloproliferative neoplasm with JAK2 V617F mutation) occurring alongside multiple myeloma 3, 4
- Some cases involve secondary polycythemia or polycythemia of undetermined etiology 2, 5
- In one case, polycythemia resolved after myeloma treatment, suggesting a possible paraneoplastic phenomenon 6
Clinical Implications
If you encounter a patient with multiple myeloma and polycythemia:
- Investigate for polycythemia vera as a separate concurrent diagnosis (check JAK2 V617F mutation)
- Consider secondary causes of polycythemia (hypoxia, erythropoietin-secreting tumors, sleep apnea, smoking)
- Evaluate for polycythemia of undetermined etiology after excluding other causes
- Look for clinical clues: hepatosplenomegaly, thrombosis history, pruritus after bathing 4
This combination represents two distinct pathological processes occurring simultaneously, not a complication of myeloma itself.